Related Experiment Video
Updated: Jul 27, 2026

08:08
A Technique for Serial Collection of Cerebrospinal Fluid from the Cisterna Magna in Mouse
Published on: November 10, 2008
101.5K
Utilizing Quantitative Analysis of CSF Volume from Clinical T1-Weighted MRI to Predict Thrombectomy Outcomes
Mohammad I Kawas1,2, Ahmad Shamulzai3,4, Kyle M Atcheson1,5
1Department of Radiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Summary
Higher cerebrospinal fluid volume (CSFV) after endovascular thrombectomy (EVT) for stroke is linked to worse functional outcomes. This imaging biomarker can help predict patient prognosis and guide treatment decisions.
Area of Science:
- Neurology
- Radiology
- Medical Imaging
Background:
- Endovascular thrombectomy (EVT) is standard for acute ischemic stroke with large vessel occlusion.
- Functional independence post-EVT varies, and brain atrophy (higher cerebrospinal fluid volume - CSFV) may influence outcomes.
- Baseline CSFV could potentially predict EVT benefit by reflecting brain health.
Purpose of the Study:
- To quantify total CSFV from T1-weighted MRI scans.
- To assess global brain atrophy using CSFV measurements.
- To determine the association between baseline CSFV and functional outcomes after successful EVT.
Main Methods:
- Retrospective analysis of 432 patients from a stroke thrombectomy registry (2015-2021).
- Included 214 patients with MRI within 14 days of EVT and 90-day mRS data.
- Used SynthSR for image enhancement and FreeSurfer for CSFV estimation, calculating CSFV percentage (CSFV%) to intracranial volume.
Main Results:
- Baseline CSFV% significantly predicted 90-day modified Rankin Scale (mRS) in ordinal regression models (p < 0.001).
- CSFV% remained an independent predictor of 90-day mRS after adjusting for clinical factors (p = 0.012).
- CSFV% did not significantly predict hemorrhagic transformation.
Conclusions:
- Increased CSFV% correlates with poorer functional outcomes following EVT.
- Total CSFV% shows potential as an imaging biomarker for prognostication in EVT patients.
- This metric may aid clinicians in determining patient prognosis before EVT.

